Hana Biosciences Receives NASDAQ Notice; Will Request Hearing
11 mars 2009 16h30 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 11, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB) today announced that the Company received a letter on March 5, 2009 from the Listing Qualifications Staff...
Hana Biosciences to Present at the 11th Annual BIO CEO & Investor Conference On February 10, 2009
02 févr. 2009 07h30 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 2, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences Phase 1 Data On Menadione, Its Novel First-in-Class Compound for Treatment-Limiting Skin Toxicity Associated With EGFR Inhibitors, to be Presented At 33rd Hawaii Dermatology Seminar
13 janv. 2009 07h30 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced an...
Hana Biosciences Appoints Thomas J. Tarlow as Vice President, Regulatory Affairs and Quality
12 janv. 2009 07h30 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 12, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences Completes Phase 1 Clinical Trial of Menadione, Its Novel First-in-class Compound for Treatment-Limiting Skin Toxicity Associated With EGFR Inhibitors
08 déc. 2008 07h30 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 8, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced the...
Hana Biosciences to Present Data On Marqibo, Its Lead Novel Anti-Cancer Compound, At 2008 American Society of Hematology (ASH) Meeting
01 déc. 2008 07h30 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 1, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences Receives NASDAQ Notification
21 nov. 2008 16h47 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 21, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, reported that it...
Hana Biosciences to Present At the 20th Annual Piper Jaffray Health Care Conference On December 3, 2008
20 nov. 2008 07h30 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 20, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences Reports Third Quarter 2008 Results
13 nov. 2008 16h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced its...
Hana Biosciences to Report Third Quarter 2008 Results and Business Update On November 13, 2008
06 nov. 2008 07h30 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, will announce its...